2-甲氧基-4,6-二甲基烟腈 | 65515-39-1

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-甲氧基-4,6-二甲基烟腈
• 英文名称: 3-cyano-4,6-dimethyl-2-methoxypyridine
• 英文别名: 2-methoxy-4,6-dimethylpyridine-3-carbonitrile；2-methoxy-3-cyano-4,6-dimethylpyridine；3-Cyano-2-methoxy-4,6-dimethylpyridine；2-methoxy-4,6-dimethylnicotinonitrile；2-methoxy-4,6-dimethyl-nicotinonitrile；2-Methoxy-4,6-dimethyl-nicotinonitril
• CAS: 65515-39-1
• 化学式: C₉H₁₀N₂O
• mdl: MFCD00124716
• 分子量: 162.191
• InChiKey: WEJLKGQPSKTCBR-UHFFFAOYSA-N

物化性质

• 熔点：
  282-284℃
• 沸点：
  294.0±35.0 °C(Predicted)
• 密度：
  1.09±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  45.9
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Methoxy-4,6-dimethylnicotinonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Methoxy-4,6-dimethylnicotinonitrile
CAS number: 65515-39-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H10N2O
Molecular weight: 162.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-甲氧基-4,6-二甲基烟腈 在 N-溴代丁二酰亚胺(NBS) 、 硫酸 作用下， 以 三氟乙酸 为溶剂， 反应 24.0h， 以92%的产率得到5-溴-2-甲氧基-4,6-二甲基烟腈
  参考文献：
  名称：

  固态吡啶3-甲醛的构象控制和光烯化：通过氢键和电子控制稳定光烯醇。

  摘要：

  我们已经研究了广泛的吡啶-3-羧醛1-5的固态光行为。如在醛1中一样，将杂原子引入到三聚甲醛中提出了固态构象上的优先权的问题。通过对两个醛1c和2c的X射线晶体结构分析已明确确定了优选的构象。结果表明，分子内氢键可用于构象控制。与均三聚甲醛在固态下进行有效的光环化成苯并环丁烯醇不同，杂原子类似物1b和1c在紫外线照射下表现出可察觉的颜色变化（从1b变为无色至浅黄色，从1c变为橙黄色）。（E）-烯醇的颜色会持续几个小时。持续照射会导致难以处理的聚合物材料。AM1计算已可靠地应用于木二酚热环化为苯并环丁烯醇，结果表明，相对于其相应的苯并环丁烯醇，1的（E）-烯醇比三聚甲醛的稳定性更高。稳定性被解释为是由于杂原子参与共振离域而产生的。通过形成氟硼酸盐很好地证明了氮原子如此作用的贡献。1a-HBF（4）和1b-HBF（4）暴露于紫外线辐射后，由于光烯醇的稳定化，很容易表现出高度红移的吸收。值得注意

  DOI：

  10.1021/jo026621n
• 作为产物：
  描述：

  2-氯-3-氰基-4,6-二甲基吡啶 在 sodium methylate 作用下， 以 甲醇 为溶剂， 生成 2-甲氧基-4,6-二甲基烟腈
  参考文献：
  名称：

  Herbicidal cyclohexane-1,3-dione derivatives

  摘要：

  公开号：

  EP0104876B1

文献信息

• [EN] ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS<br/>[FR] ACTIVATEUR D'INHIBITEURS DE L'HOMOLOGUE 2 DE ZESTE
  申请人：GLAXOSMITHKLINE IP NO 2 LTD

  公开号：WO2014195919A1

  公开（公告）日：2014-12-11

  This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.

  这项发明涉及到按照式（I）的新化合物，这些化合物是增强子Zeste同源物2（EZH2）的抑制剂，以及含有它们的药物组合物，它们的制备方法，以及它们在治疗癌症方面的用途。
• [EN] INHIBITORS OF EZH2<br/>[FR] INHIBITEURS DE L'EZH2
  申请人：LILLY CO ELI

  公开号：WO2017035060A1

  公开（公告）日：2017-03-02

  The present invention relates to compounds that inhibit activity of the histone lysine methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, such as hematologic and solid tumors.

  本发明涉及抑制组蛋白赖氨酸甲基转移酶Enhancer of Zeste Homolog 2（EZH2）活性的化合物，包括这些化合物的药物组合物，以及使用这些化合物治疗癌症，如血液学和实体肿瘤的方法。
• ARYL AND HETEROARYL FUSED LACTAMS
  申请人：PFIZER INC.

  公开号：US20140179667A1

  公开（公告）日：2014-06-26

  This invention relates to compounds of general formula (I) in which R 1 , R 2 , U, V, L, M, R 5 , m, X, Y and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.

  本发明涉及具有通用公式（I）的化合物，其中R1，R2，U，V，L，M，R5，m，X，Y和Z定义如本文中所述，以及药用可接受的盐，包含此类化合物和盐的药物组合物，以及使用此类化合物、盐和组合物治疗异常细胞生长，包括癌症的方法。
• [EN] ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS<br/>[FR] AMPLIFICATEUR DES INHIBITEURS DE L'HOMOLOGUE 2 DE ZESTE
  申请人：GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD

  公开号：WO2017002064A1

  公开（公告）日：2017-01-05

  This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.

  这项发明涉及到按照式（I）的新化合物，这些化合物是增强子Zeste同源物2（EZH2）的抑制剂，以及含有它们的药物组合物，它们的制备过程，以及它们在治疗癌症方面的用途。
• [EN] SUBSTITUTED PYRIDONES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP)<br/>[FR] PYRIDONES SUBSTITUES INHIBITEURS DE LA POLY(ADP-RIBOSE) POLYMERASE (PARP)
  申请人：AVENTIS PHARMA INC

  公开号：WO2005097750A1

  公开（公告）日：2005-10-20

  The present invention discloses and claims a series of 2,3,5-substituted pyridone derivatives as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5'-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.

  本发明公开并声明了一系列如下定义的2,3,5-取代吡啶酮衍生物。本发明还涉及制备这些化合物的方法。本发明的化合物是多聚腺苷酸二磷酸核糖酶（PARP）的抑制剂，因此在制药剂中特别用于治疗和/或预防各种疾病，包括与中枢神经系统和心血管疾病相关的疾病。

表征谱图